Qed Therapeutics

Qed Therapeutics is a small Molecule Targeting Tyrosine Kinase Receptors founded in 2018.

Overview

Qed Therapeutics is a small Molecule Targeting Tyrosine Kinase Receptors founded in 2018.

Website:
- http://qedtx.com
Social accounts: linkedin twitter

Industries

Qed Therapeutics is active in the following industries: